Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer

scientific article published on 15 May 2007

Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1014095086
P356DOI10.1245/S10434-007-9410-Z
P698PubMed publication ID17503156

P50authorTristan D YanQ62035141
P2093author name stringPaul H Sugarbaker
Lana Bijelic
P433issue8
P921main subjectcolorectal carcinomaQ25493920
colorectal cancerQ188874
failure analysisQ1022240
peritoneal carcinomatosisQ2071182
P304page(s)2281-2288
P577publication date2007-05-15
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleFailure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer
P478volume14

Reverse relations

cites work (P2860)
Q336474185-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice
Q35234968Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only
Q34391061Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Q34343492Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients
Q33594164Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?
Q90127233Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy
Q31031044Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy
Q45193745Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy
Q41132998Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer
Q26768299Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes
Q50868429Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies.
Q39013815Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC.
Q60948065Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
Q37855303Treatment recommendations for metastatic colorectal cancer
Q33416610Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy
Q83393453[Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis]

Search more.